Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Total 13F shares
-
12,209,438
-
Share change
-
+5,189,071
-
Total reported value
-
$125,630,881
-
Put/Call ratio
-
83%
-
Price per share
-
$10.29
-
Number of holders
-
70
-
Value change
-
+$52,360,330
-
Number of buys
-
57
-
Number of sells
-
13
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2015
As of 30 Jun 2015,
Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,209,438 shares.
The largest 10 holders included
EAGLE ASSET MANAGEMENT INC, FMR LLC, Novo A/S, BlackRock Fund Advisors, BALYASNY ASSET MANAGEMENT LLC, VANGUARD GROUP INC, Marshall Wace LLP, RENAISSANCE TECHNOLOGIES LLC, EMERALD MUTUAL FUND ADVISERS TRUST, and STATE STREET CORP.
This page lists
70
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.